Search details
1.
Erythroid/megakaryocytic differentiation confers BCL-XL dependency and venetoclax resistance in acute myeloid leukemia.
Blood
; 141(13): 1610-1625, 2023 03 30.
Article
in English
| MEDLINE | ID: mdl-36508699
2.
Multi-parametric single cell evaluation defines distinct drug responses in healthy hematologic cells that are retained in corresponding malignant cell types.
Haematologica
; 105(6): 1527-1538, 2020 06.
Article
in English
| MEDLINE | ID: mdl-31439679
3.
Phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemia.
Haematologica
; 105(3): 708-720, 2020 03.
Article
in English
| MEDLINE | ID: mdl-31296572
4.
An arms-race against resistance: leukemic stem cells and lineage plasticity.
Mol Oncol
; 18(3): 475-478, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38375990
5.
Opsonization-independent antigen-specific recognition by myeloid phagocytes expressing monoclonal antibodies.
Sci Adv
; 9(35): eadg1812, 2023 Sep.
Article
in English
| MEDLINE | ID: mdl-37656789
6.
Combinatorial BCL2 Family Expression in Acute Myeloid Leukemia Stem Cells Predicts Clinical Response to Azacitidine/Venetoclax.
Cancer Discov
; 13(6): 1408-1427, 2023 06 02.
Article
in English
| MEDLINE | ID: mdl-36892565
Results
1 -
6
de 6
1
Next >
>>